Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

3:05 PM ET 8-K
Capital Raise Willis Lease Finance Corp WLFC

Willis Lease Finance Capital Raise of $35M

Willis Lease Finance Corporation closed a private placement of 1,750,000 shares of Series B Preferred Stock to the Development Bank of Japan Inc. for $35 million. The Series B Preferred Stock carries an 8.09% annual dividend and ranks senior to common stock but pari passu with existing Series A Preferred Stock.

Value
$35M
Counterparty
Development Bank of Japan Inc.
2:11 PM ET 8-K
Bankruptcy & Restructuring Leslie's, Inc. LESLQ

Leslie's Bankruptcy & Restructuring

Leslie’s, Inc. and its subsidiaries filed voluntary Chapter 11 petitions in the U.S. Bankruptcy Court for the Southern District of Texas to implement a pre-arranged reorganization plan. The company entered into a Restructuring Support Agreement (RSA) with lenders holding 81.1% of its term loans to eliminate approximately $685 million (90%) of debt and secure $150 million in new capital. As part of the restructuring, the company is closing 76 stores and expects to emerge from bankruptcy in early 2027.

Counterparty
Consenting Term Loan Lenders
1:36 PM ET 8-K
Capital Raise Bbcms Mortgage Trust 2026-M1

Bbcms Mortgage Trust 2026-M1 Capital Raise of $548M

BBCMS Mortgage Trust 2026-M1 completed the issuance of $548.273 million in Commercial Mortgage Pass-Through Certificates, Series 2026-M1. The public certificates were sold to a group of underwriters led by Barclays Capital, with proceeds used to purchase a portfolio of 37 commercial, multifamily, and manufactured housing community mortgage loans.

Value
$548M
Counterparty
Barclays Capital Inc.
1:26 PM ET 8-K
M&A Deal Nuveen Farmland REIT

Nuveen Farmland REIT Signs $20.6M M&A Deal with IAI USA Fund II, LLC and IAI USA, LLC

Nuveen Farmland REIT completed the acquisition of two agricultural properties totaling approximately 3,485.3 gross acres in Illinois and Mississippi for a combined purchase price of approximately $20.6 million. The acquisitions were financed using proceeds from the company's continuous private offering and represent a strategic expansion of its farmland portfolio.

Value
$20.6M
Counterparty
IAI USA Fund II, LLC and IAI USA, LLC
12:23 PM ET 8-K
Capital Raise Omnitek Engineering Corp OMTK

Omnitek Engineering Capital Raise of $1.05M

Omnitek Engineering Corp. raised $0.5 million through the sale of 5,000 shares of Series A Preferred Stock to Hard Rock Holdco, LLC, with an agreement to sell an additional 5,000 shares for $0.5 million within 90 days. The company also issued a five-year warrant to a third party for $0.55 million, exercisable for approximately 91.7 million common shares. The issuance of the Series A Preferred Stock resulted in a change of control, as the shares carry significant voting rights (50,000 votes per share).

Value
$1.05M
Counterparty
Hard Rock Holdco, LLC
Term
5 years
12:12 PM ET 8-K
Capital Raise Brookfield Private Equity Fund LP

Brookfield Private Equity Fund Capital Raise of $8.76M

Brookfield Private Equity Fund LP sold unregistered limited partnership units for aggregate consideration of approximately $8.76 million on September 1, 2026. The sale was part of a continuous private offering that has raised a total of $402.13 million for the BPE Program since November 2025.

Value
$8.76M
9:38 AM ET 8-K
Capital Raise Digimarc Corp DMRC

Digimarc Capital Raise of $18.2M

Digimarc Corporation entered into purchase agreements for a registered direct offering of 4,500,000 common shares at a price of $4.04 per share. The offering, led by an existing investor, is expected to generate gross proceeds of approximately $18.2 million for general corporate purposes. The agreement includes participation rights for investors in future offerings and certain resale registration rights.

Value
$18.2M
9:30 AM ET 8-K
M&A Deal DigitalBridge Group, Inc. DBRHP

DigitalBridge Group M&A Deal with Duncan Holdco LLC

DigitalBridge Group, Inc. completed its merger with Duncan Holdco LLC, resulting in the company becoming a private indirect subsidiary of Duncan Holdco. Under the terms of the agreement, each share of DigitalBridge common stock was converted into the right to receive $16.00 in cash.

Counterparty
Duncan Holdco LLC
9:20 AM ET 8-K
Clinical Trial Data Q32 Bio Inc. QTTB

Q32 Bio Clinical Trial Data

Q32 Bio presented additional 36-week results and initial 16-week off-drug findings from its SIGNAL-AA Phase 2a trial of bempikibart in patients with severe alopecia areata. The data showed clinically meaningful efficacy, including a 35.3% mean reduction in SALT scores, and supported the drug's advancement into a registration-directed program in the first half of 2027.

“Bempikibart’s robust efficacy data and durability observed across the 36-week treatment period and 16-week off-drug period in both JAK inhibitor-experienced and JAK inhibitor-naïve patients, changes on biomarkers supportive of its bifunctional mechanism, and its favorable safety and tolerability profile support its continued development in a registration-directed program in patients with severe or very severe alopecia areata as well as in expanded alopecia areata populations and other autoimmune and inflammatory indications.”

Jodie Morrison, Chief Executive Officer of Q32 Bio
9:20 AM ET 8-K/A
M&A Deal Reliance Global Group, Inc. XGPU

Reliance Global Group M&A Deal Update

Reliance Global Group, Inc. filed an amendment to its previous 8-K to correct the closing date of a completed acquisition transaction. The closing was finalized on September 24, 2026, following the delivery of the cash portion of the payment and a promissory note.

9:16 AM ET 8-K
Capital Raise Rent the Runway, Inc. RENT

Rent the Runway Capital Raise of $15M

Rent the Runway launched a $15 million rights offering for its Class A common stockholders of record as of September 25, 2026. Each right allows holders to purchase approximately 0.1251 shares of Class A Common Stock at a subscription price of $3.55 per share, with the offering set to expire on October 14, 2026.

Value
$15M
9:14 AM ET 8-K
M&A Deal Trio Petroleum Corp TPET

Trio Petroleum M&A Deal with Marlin Resources Ltd.

Trio Petroleum's Canadian subsidiary entered into a definitive agreement to acquire 24 oil wells and a water disposal facility in Saskatchewan's Lloydminster region from Marlin Resources Ltd. The consideration includes CAD$800,000 in cash and the transfer of an underutilized water disposal asset. The deal adds 37 barrels of oil per day of current production and provides significant upside through existing-well workovers and a new Cummings multilateral drilling opportunity.

Counterparty
Marlin Resources Ltd.
9:06 AM ET 8-K
Capital Raise Indaptus Therapeutics, Inc. INDP

Indaptus Therapeutics Capital Raise of $24M

Indaptus Therapeutics entered into notices and consents to extend the closing date of a previously announced $24.0 million private placement of common stock. The 'Outside Date' for the transaction was moved from September 29, 2026, to October 16, 2026, to allow additional time for closing conditions to be satisfied.

Value
$24M
9:00 AM ET 8-K
Partnership Vida Global Inc. VIDA

Vida Global Partnership with Avant

VIDA Global Inc. has entered into a strategic partnership with AVANT, a leading Technology Services Distributor, to integrate Vida's AI agent platform into AVANT's technology portfolio. The collaboration allows AVANT's network of Trusted Advisors to offer Vida's digital workforce solutions, which automate workflows across voice, SMS, email, and chat, to enterprise clients.

Counterparty
AVANT
9:00 AM ET 8-K
Divestiture Capital Bancorp Inc CBNK

Capital Bancorp Divestiture

Capital Bank, N.A., a subsidiary of Capital Bancorp, Inc., entered into a purchase and assumption agreement to sell its branch office in North Riverside, Illinois. The transaction includes the sale of certain loans and assets and the assumption of approximately $123.9 million in deposits by another financial institution for an estimated deposit premium of $3.3 million.

8:53 AM ET 8-K
M&A Deal Surf Air Mobility Inc. SRFM

Surf Air Mobility M&A Deal with Palantir Technologies Inc.

Surf Air Mobility Inc. registered the issuance of 4,644,922 shares of common stock to Palantir Technologies Inc. as consideration for license fees and professional services. The shares were issued under an existing software license agreement, and the filing serves to provide the legal opinion regarding the validity of these shares.

Counterparty
Palantir Technologies Inc.
8:52 AM ET 8-K
Clinical Trial Data Silexion Therapeutics Corp SLXN

Silexion Therapeutics Clinical Trial Data

Silexion Therapeutics has successfully dosed the first patient in its Phase 2/3 clinical trial of SIL204 for the treatment of locally advanced pancreatic cancer (LAPC). The trial evaluates SIL204 in combination with standard chemotherapy using a dual-route delivery strategy involving both intratumoral and subcutaneous administration. This milestone marks the transition of the company's lead RNAi program into active clinical execution across sites in Israel and Germany.

Counterparty
Tel Aviv Sourasky Medical Center
8:43 AM ET 8-K
M&A Deal Trump Media & Technology Group Corp. DJT

Trump Media & Technology Group Signs $300M M&A Deal with TAE Technologies, Inc.

Trump Media & Technology Group (TMTG) filed a Form S-4 registration statement for its previously announced all-stock merger with TAE Technologies, a fusion energy and power management company. In connection with the filing, the parties amended a convertible promissory note allowing TAE to draw down up to $300 million in total funding from TMTG. Upon closing, TMTG and TAE shareholders will each own approximately 50% of the combined publicly traded enterprise.

Value
$300M
Counterparty
TAE Technologies, Inc.
8:40 AM ET 8-K
M&A Deal Skyworks Solutions, Inc. SWKS

Skyworks Solutions M&A Deal with Qorvo, Inc.

Skyworks Solutions announced it has received all necessary regulatory clearances for its previously announced merger with Qorvo, Inc. The companies expect to close the cash-and-stock transaction on or about October 5, 2026, creating a global leader in high-performance radio frequency and analog semiconductors.

Counterparty
Qorvo, Inc.
8:35 AM ET 8-K
Contract Win Elmet Group Co. ELMT

Elmet Group Wins $36M Contract from Defense Logistics Agency

The Elmet Group's subsidiary, Elmet Technologies, was awarded a $36 million contract by the Defense Logistics Agency (DLA) to supply high-performance molybdenum and tungsten alloys and precision wire. These materials will be supplied to the U.S. National Defense Stockpile for use in jet engine components and other aerospace applications. This award follows a much larger $2 billion DLA contract announced earlier in the month, further solidifying the company's role as a critical domestic supplier of refractory metals.

Value
$36M
Counterparty
Defense Logistics Agency
8:31 AM ET 8-K
M&A Deal Sizzle Acquisition Corp. II SZZL

Sizzle Acquisition Corp. II M&A Deal with Trasteel Holding S.A.

Sizzle Acquisition Corp. II entered into an amendment to its existing business combination agreement with Trasteel Holding S.A. to extend the PCAOB audit delivery deadline to September 30, 2026. The amendment also specifies that the post-closing board of directors will consist of five members, with four appointed by Trasteel and one by Sizzle II.

Counterparty
Trasteel Holding S.A.
8:22 AM ET 8-K
M&A Deal Integer Holdings Corp ITGR

Integer Holdings Signs $5.7B M&A Deal with KKR

Integer Holdings Corporation received early termination of the HSR Act waiting period for its pending $5.7 billion acquisition by KKR affiliates. This regulatory milestone satisfies a key closing condition for the merger, which is expected to close by the end of 2026 following a stockholder vote on October 21, 2026.

Value
$5.7B
Counterparty
KKR (Kohlberg Kravis Roberts & Co. L.P.)
8:05 AM ET 8-K
Product Launch Celcuity Inc. CELC

Celcuity Product Launch

Celcuity Inc. announced the commercial availability of REVTORPYK™ (gedatolisib) in the United States for patients with HR+/HER2- advanced breast cancer without a PIK3CA mutation. The therapy, which was FDA-approved in July 2026, is the first to inhibit all class I PI3K isoforms and mTOR complexes to blockade the PAM pathway. The company has also launched the REVTORPYK Support Services program to assist with patient access and financial assistance.

8:04 AM ET 8-K
M&A Deal Iron Horse Acquisition II Corp. IRHO

Iron Horse Acquisition II M&A Deal with Electra Vehicles, Inc.

Iron Horse Acquisition II Corp. (IRHO) provided a status update on its pending merger with Electra Vehicles, Inc., an AI battery intelligence company. The update highlights new customer wins for Electra, including Mooving and Omega Seiki Mobility, and progress toward the Nasdaq listing five months after signing the definitive business combination agreement.

Counterparty
Electra Vehicles, Inc.
8:01 AM ET 8-K
Product Launch Crypto Co CRCW

Crypto Product Launch

The Crypto Company has launched the private beta testnet for Frame, its quantum-resistant Layer 1 blockchain. The network is designed for sub-two-second settlement and utilizes NIST-standard post-quantum digital signatures (ML-DSA-87) to ensure long-term security against quantum computing threats.

“Frame’s testnet going live is a real milestone, and I am excited about how far the team has come and what Frame is going to be. It is amazing to watch transactions flowing on-chain and see people lighting up when they experience for themselves what this platform really unlocks.”

Ron Levy, Chief Executive Officer of TCC

“We set out to build a Layer 1 that is quantum-resistant from genesis, and now we have one, designed for settlement in under two seconds. That combination lets people and agents move across chains without waiting, and without worrying about tomorrow’s threats.”

Sean Docherty, Chief Blockchain Officer of TCC
7:32 AM ET 8-K
M&A Deal Aperture AC APUR

Aperture AC M&A Deal with Valley Oasis Development LLC

Aperture AC's merger target, Atlantic HPC Group Inc, completed the acquisition of 100% of Valley Oasis Development LLC, a Tennessee-based entity holding 29 MW of contracted power capacity. The acquisition increases Atlantic's total utility-approved capacity to 127 MW across four states as it prepares for its business combination with Aperture. The site is zoned for heavy industrial use, making it suitable for bitcoin mining and AI compute deployments.

Counterparty
Valley Oasis Development LLC
7:24 AM ET 8-K
Clinical Trial Data Rafael Holdings, Inc. RFL

Rafael Holdings Clinical Trial Data

Rafael Holdings announced topline results from its pivotal Phase 3 TransportNPC study evaluating Trappsol Cyclo in 94 patients with Niemann-Pick Disease Type C. While the study did not achieve statistical significance on the primary endpoint in the overall population, a prespecified analysis of patients on background therapy (83% of the study) showed a statistically significant slowing of disease progression. The company remains on track to submit a New Drug Application (NDA) to the FDA in the fourth quarter of 2026.

Counterparty
Cyclo Therapeutics, LLC
Term
96 weeks
Earnings call
Sep 30, 2026, 8:30 AM ET
7:18 AM ET 8-K
Nasdaq/NYSE Compliance Notice Professional Diversity Network, Inc. IPDN

Professional Diversity Network Nasdaq/NYSE Compliance Notice

Professional Diversity Network, Inc. has regained compliance with Nasdaq's $1.00 minimum bid price requirement for continued listing. The company's common stock maintained a closing bid price at or above $1.00 for 10 consecutive business days following a previously announced reverse stock split. Nasdaq has officially closed the matter, resolving the deficiency notice originally issued on June 5, 2026.

Counterparty
The Nasdaq Stock Market LLC
7:14 AM ET 8-K
Clinical Trial Data Jade Biosciences, Inc. JBIO

Jade Biosciences Clinical Trial Data

Jade Biosciences announced preclinical data for JADE301, an anti-interferon beta monoclonal antibody being developed for dermatomyositis. The data demonstrated high-affinity binding, potent inhibition of downstream signaling, and a differentiated pharmacokinetic profile supporting infrequent subcutaneous dosing. The company expects to initiate a Phase 1 clinical trial in healthy volunteers in Q4 2026, with interim data anticipated in the second half of 2027.

7:06 AM ET 8-K
M&A Deal Onar Holding Corp ONAR

Onar Holding Signs $27.8M M&A Deal with Advertise Purple LLC

ONAR Holding Corporation completed the acquisition of Advertise Purple LLC, a leading affiliate marketing agency, for total consideration of up to $27.825 million. The deal includes $12.825 million in cash, a $7.0 million promissory note, and up to $8.0 million in potential earnout payments based on gross profit thresholds through 2029. The acquisition is described as the largest in ONAR's history, significantly increasing its pro forma revenue and adding the Bloom data and analytics platform to its technology division.

Value
$27.8M
Counterparty
Advertise Purple LLC

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.